<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="371939">
  <stage>Registered</stage>
  <submitdate>29/11/2016</submitdate>
  <approvaldate>2/12/2016</approvaldate>
  <actrnumber>ACTRN12616001667404</actrnumber>
  <trial_identification>
    <studytitle>Experience of a diagnosis of advanced melanoma: The perspective of bereaved family carers</studytitle>
    <scientifictitle>A changing treatment paradigm: Bereaved family carers' perspectives of supportive and palliative care needs in advanced melanoma</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Advanced melanoma</healthcondition>
    <conditioncode>
      <conditioncode1>Cancer</conditioncode1>
      <conditioncode2>Malignant melanoma</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>This study explores the experiences of bereaved family carers of persons who died as a result of advanced melanoma. The study uses in-depth interviews to examine the issues from the carer perspective. Single interviews will be conducted and will range in duration from 30 minutes to 90 minutes.</interventions>
    <comparator>No control group</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Not applicable</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Gain an in-depth understanding of experiences of health service provision of bereaved carers of patients with advanced melanoma from across three health care settings by carer interview.  </outcome>
      <timepoint>One off Interview per carer will be conducted 2 to 18 months post bereavement.</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>The ability of health care services to meet the support needs of patients and family carers will be determined by carer interview.</outcome>
      <timepoint>One off Interview per carer will be conducted 2 to 18 months post bereavement.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Elements and processes of service provision that contribute to an effective model of support are identified through carer interview.</outcome>
      <timepoint>One off Interview per carer will be conducted 2 to 18 months post bereavement.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Being a bereaved family carer who provided the majority of care for a person who died 2 to 18 months previously as a result of melanoma; being a bereaved family carer of person who received treatment at Peter MacCallum Cancer Centre, Melanoma Institute of Australia or Princess Alexandra Hospital; and being 18 years or older and English speaking.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>Bereaved carers who indicate they do not wish to participate.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods>Qualitative research</statisticalmethods>
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs>Psychosocial</purposeobs>
    <duration>Cross-sectional</duration>
    <selection>Convenience sample</selection>
    <timing>Prospective</timing>
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate />
    <actualstartdate>30/05/2016</actualstartdate>
    <anticipatedenddate>28/02/2017</anticipatedenddate>
    <actualenddate />
    <samplesize>24</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <anticipatedlastvisitdate>15/03/2017</anticipatedlastvisitdate>
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>NSW,QLD,VIC</recruitmentstate>
    <hospital>Princess Alexandra Hospital - Woolloongabba</hospital>
    <hospital>Peter MacCallum Cancer Centre - Melbourne</hospital>
    <hospital>The Poche Centre, Melanoma Institute Australia - North Sydney</hospital>
    <postcode>4102 - Woolloongabba</postcode>
    <postcode>3000 - Melbourne</postcode>
    <postcode>2060 - North Sydney</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>Queensland University of Technology</primarysponsorname>
    <primarysponsoraddress>60 Musk Avenue
Kelvin Grove Qld 4059</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Charities/Societies/Foundations</fundingtype>
      <fundingname>Sigma Theta Tau International</fundingname>
      <fundingaddress>550 W. North St.
Indianapolis, IN 46202
</fundingaddress>
      <fundingcountry>United States of America</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
    <othercollaborator>
      <othercollaboratortype>Hospital</othercollaboratortype>
      <othercollaboratorname>Peter MacCallum Cancer Centre</othercollaboratorname>
      <othercollaboratoraddress>305 Grattan St
Melbourne VIC 3000</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Other</othercollaboratortype>
      <othercollaboratorname>Melanoma Institute of Australia (The Poche Centre)</othercollaboratorname>
      <othercollaboratoraddress>40 Rocklands Rd
North Sydney NSW 2060</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
    <othercollaborator>
      <othercollaboratortype>Hospital</othercollaboratortype>
      <othercollaboratorname>Princess Alexandra Hospital </othercollaboratorname>
      <othercollaboratoraddress>199 Ipswich Rd
Woolloongabba QLD 4102</othercollaboratoraddress>
      <othercollaboratorcountry>Australia</othercollaboratorcountry>
    </othercollaborator>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The primary purpose of this study is to identify supportive and palliative care needs  from the perspective of bereaved family carers of deceased advanced melanoma patients from diagnosis of advanced disease to death.

Who is it for?
You may be eligible to participate in this study if you are aged 18 or over, are English-speaking and were the main carer of a person who died 2 to 18 months previously as a result of melanoma.

Study details
All participants in this study will complete a single 30-90 minute interview about supportive care needs from diagnosis to death of a family member with advanced melanoma. It is hoped that from these interviews, researchers will identify the supportive care needs of these individuals. 
</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Metro South Human Research Ethics Committee</ethicname>
      <ethicaddress>PAH Centres for Health Research
Level 7, Translational Research Institute
37 Kent Street
Woolloongabba QLD 4102</ethicaddress>
      <ethicapprovaldate>17/02/2016</ethicapprovaldate>
      <hrec>HREC/16/QPAH/039</hrec>
      <ethicsubmitdate>13/01/2016</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Queensland University of Technology</ethicname>
      <ethicaddress>60 Musk Avenue
Kelvin Grove Qld 4059</ethicaddress>
      <ethicapprovaldate>21/03/2016</ethicapprovaldate>
      <hrec>1600000212</hrec>
      <ethicsubmitdate>1/03/2016</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Peter MacCallu,m Cancer Centre</ethicname>
      <ethicaddress>305 Grattan St 
Melbourne VIC 3000</ethicaddress>
      <ethicapprovaldate>16/03/2016</ethicapprovaldate>
      <hrec>SSA/16/PMCC/35</hrec>
      <ethicsubmitdate>7/03/2016</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
    <ethicscommitee>
      <ethicname>Melanoma Institute of Australia</ethicname>
      <ethicaddress>The Poche Centre
40 Rocklands Road
Wollstonecraft NSW 2065</ethicaddress>
      <ethicapprovaldate>11/11/2016</ethicapprovaldate>
      <hrec>MIA2015/172</hrec>
      <ethicsubmitdate>1/11/2016</ethicsubmitdate>
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Dr</title>
      <name>Jenny Fox</name>
      <address>Queensland University of Technology
60 Musk Avenue 
Kelvin Grove Qld 4059</address>
      <phone>+61 7 31380136</phone>
      <fax />
      <email>jennifer.fox@qut.edu.au</email>
      <country>Australia</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Jenny Fox</name>
      <address>Queensland University of Technology
60 Musk Avenue 
Kelvin Grove Qld 4059</address>
      <phone>+61 7 31380136</phone>
      <fax />
      <email>jennifer.fox@qut.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Jenny Fox</name>
      <address>Queensland University of Technology
60 Musk Avenue 
Kelvin Grove Qld 4059</address>
      <phone>+61 7 31380136</phone>
      <fax />
      <email>jennifer.fox@qut.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title>Dr</title>
      <name>Jenny Fox</name>
      <address>Queensland University of Technology
60 Musk Avenue 
Kelvin Grove Qld 4059</address>
      <phone>+61 7 31380136</phone>
      <fax />
      <email>jennifer.fox@qut.edu.au</email>
      <country />
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>